Aclaris Therapeutics (NasdaqGS:ACRS) 2025 Conference November 12, 2025 01:20 PM ET Speaker2Awesome. Good afternoon, everyone. It's my pleasure to introduce the Aclaris Therapeutics team. Hugh Davis, Roland Kolbeck, and Will Roberts here joining us this afternoon. Maybe we could start off with just a brief overview of the company. Maybe, Hugh, do you want to start with that?Speaker1Sure. Yeah, hi. Thanks for having us. Aclaris is a clinical stage biotech. We have three assets in the clinic and another to com ...